Clinical Reviews in Allergy and Immunology,volume 29,issue 1  (02-2013)

Period of time： 2013年1期

Publisher： Humana Press, Inc

Founded in： 1983

Total resources： 48

ISSN： 1080-0549

Subject： R3 Basic Medical

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Reviews in Allergy and Immunology,volume 29,issue 1

Menu

Introduction: Anti-IgE

By Bochner Bruce,Saini Sarbjit in (2005)

Clinical Reviews in Allergy and Immunology,volume 29,issue 1 , Vol. 29, Iss. 1, 2005-02 , pp. 1-2

Humana Press, Inc

Abstract Access to resources Recommend Favorite

Omalizumab in asthma: Approval and postapproval experience

By Chiang Dean,Clark Justin,Casale Thomas in (2005)

Clinical Reviews in Allergy and Immunology,volume 29,issue 1 , Vol. 29, Iss. 1, 2005-02 , pp. 3-16

Humana Press, Inc

Abstract Access to resources Recommend Favorite

Omalizumab: Other indications and unanswered questions

By Mankad Vaishali,Burks A. in (2005)

Clinical Reviews in Allergy and Immunology,volume 29,issue 1 , Vol. 29, Iss. 1, 2005-02 , pp. 17-30

Humana Press, Inc

Abstract Access to resources Recommend Favorite

Safety and tolerability of omalizumab (Xolair®), a recombinant humanized monoclonal anti-IgE antibody

By Deniz Yamo,Gupta Niroo in (2005)

Clinical Reviews in Allergy and Immunology,volume 29,issue 1 , Vol. 29, Iss. 1, 2005-02 , pp. 31-48

Humana Press, Inc

Abstract Access to resources Recommend Favorite

IgE and FcɛRI regulation

By MacGlashan Donald in (2005)

Clinical Reviews in Allergy and Immunology,volume 29,issue 1 , Vol. 29, Iss. 1, 2005-02 , pp. 49-60

Humana Press, Inc

Abstract Access to resources Recommend Favorite

Anti-CD23

By Rosenwasser Lanny,Meng Jianfeng in (2005)

Clinical Reviews in Allergy and Immunology,volume 29,issue 1 , Vol. 29, Iss. 1, 2005-02 , pp. 61-72

Humana Press, Inc

Abstract Access to resources Recommend Favorite

Total 6 item(s)